RedSail Technologies’ vp of clinical services discusses awareness and education gaps in how patients understand GLP-1s.
Kristen Hartzell
Advertisement
Kristen Hartzell, Pharm D, VP Commercial Ops & Clinical Strategy of RedSail Technologies
Articles by Kristen Hartzell
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
DTP is Scaling Fast, the Safety Infrastructure is Not
2
Insilico Medicine and CMS Enter $177 Million AI-Powered Drug Discovery Collaboration
3
FDA Issues CRL to Elevar Therpaeutics for Combination of Rivoceranib and Camrelizumab
4
U.S. Supreme Court Weighs Inducement Liability Beyond FDA Carve-Out Labels
5